HomeSMARTS Resources

Substance Misuse, Assessment, Recovery, Treatment & Surveillance

Access substance abuse-specific and committee-related (member access only) resources and documents here.

Resources & Documents

Articles

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023 (Morbidity and Mortality Weekly Report, Feb 2024) A study in New York showed no benefits to administration of 8-mg intranasal naloxone compared with 4-mg product were found. More data are needed to determine whether higher-dose intranasal naloxone would provide added benefits.
A call for compassionate opioid overdose response (International Journal of Drug Policy, Sept 2024) A call to action for an opioid overdose response standard of care that centers the voices of people who use drugs.

Statements

Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at this Time (NASEMSO Statement of Endorsement, Jul 2024) An endorsement of the Joint Position Statement from the American College of Medical Toxicology and the American
Academy of Clinical Toxicology.